Effects of goshajinkigan, hachimijiogan, and rokumigan on mechanical allodynia induced by paclitaxel in mice

Journal of Traditional and Complementary Medicine

Volumn 4, Issue 4, 2014, Pages 293-297

  Andoh, Tsugunobu ^a   Kitamura, Ryo ^a   Fushimi, Hirotoshi ^a   Komatsu, Katsuko ^a   Shibahara, Naotoshi ^a   Kuraishi, Yasushi ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Goshajinkigan; Hachimijiogan; Mechanical allodynia; Paclitaxel; Rokumigan

Indexed keywords

EID: 84908464442     PISSN: None     EISSN: 22254110     Source Type: Journal    
DOI: 10.4103/2225-4110.128906     Document Type: Article

References (21)

1. Chang AY, Garrow GC. Pilot study of vinorelbine (Navelbine) and paclitaxel (Taxol) in patients with refractory breast cancer and lung cancer. Semin Oncol 1995;22 2 Suppl 5:66-71.
2. Wani MC, Taylor HL, Wall ME, Coggon P, McPhail AT. Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. J Am Chem Soc 1971;93:2325-7.
3. Dougherty PM, Cata JP, Cordella JV, Burton A, Weng HR. Taxol-induced sensory disturbance is characterized by preferential impairment of myelinated fiber function in cancer patients. Pain 2004;109:132-42.
4. Rao RD, Michalak JC, Sloan JA, Loprinzi CL, Soori GS, Nikcevich DA, et al. North Central Cancer Treatment Group. Efficacy of gabapentin in the management of chemotherapy-induced peripheral neuropathy: A phase 3 randomized, double-blind, placebo-controlled, crossover trial (N00C3). Cancer 2007;110:2110-8.
5. Wolf S, Barton D, Kottschade L, Grothey A, Loprinzi C. Chemotherapy-induced peripheral neuropathy: Prevention and treatment strategies. Eur J Cancer 2008;44:1507-15.
6. Carlson K, Ocean AJ. Peripheral neuropathy with microtubule-targeting agents: Occurrence and management approach. Clin Breast Cancer 2011;11:73-81.
7. Kaku H, Kumagai S, Onoue H, Takada A, Shoji T, Miura F, et al. Objective evaluation of the alleviating effects of Goshajinkigan on peripheral neuropathy induced by paclitaxel/carboplatin therapy: A multicenter collaborative study. Exp Ther Med 2012;3:60-5.
8. Kono T, Hata T, Morita S, Munemoto Y, Matsui T, Kojima H, et al. Goshajinkigan oxaliplatin neurotoxicity evaluation (GONE): A phase 2, multicenter, randomized, double-blind, placebo-controlled trial of goshajinkigan to prevent oxaliplatin-induced neuropathy. Cancer Chemother Pharmacol 2013;72:1283-90.
9. Ushio S, Egashira N, Sada H, Kawashiri T, Shirahama M, Masuguchi K, et al. Goshajinkigan reduces oxaliplatin-induced peripheral neuropathy without affecting anti-tumour efficacy in rodents. Eur J Cancer 2012;48:1407-13.
10. Bahar MA, Andoh T, Ogura K, Hayakawa Y, Saiki I, Kuraishi Y. Herbal medicine goshajinkigan prevents paclitaxel-induced mechanical allodynia without impairing antitumor activity of paclitaxel. Evid Based Complement Alternat Med 2013;2013:e849754.
11. Gauchan P, Andoh T, Kato A, Sasaki A, Kuraishi Y. Effects of the prostaglandin E1 analog limaprost on mechanical allodynia caused by chemotherapeutic agents in mice. J Pharmacol Sci 2009;109:469-72.
12. Kitamura R, Andoh T, Fushimi H, Komatsu K, Shibahara N, Kuraihsi Y. Involvement of descending monoaminergic systems in antiallodynic effect of goshajinkigan in oxaliplatin-treated mice. J Tradit Med 2013;30:183-9.
13. Katsuyama S, Sato K, Yagi T, Kishikawa Y, Nakamura H. Effects of repeated milnacipran and fluvoxamine treatment on mechanical allodynia in a mouse paclitaxel-induced neuropathic pain model. Biomed Res 2013;34:105-11.
14. Fidanboylu M, Griffiths LA, Flatters SJ. Global inhibition of reactive oxygen species (ROS) inhibits paclitaxel-induced painful peripheral neuropathy. PLoS One 2011;6:e25212.
15. Xie F, Li X, Sun K, Chu Y, Cao H, Chen N, et al. An experimental study on drugs for improving blood circulation and removing blood stasis in treating mild chronic hepatic damage. J Tradit Chin Med 2001;21:225-31.
16. Li H, Wang Q. Evaluation of free hydroxyl radical scavenging activities of some Chinese herbs by capillary zone electrophoresis with amperometric detection. Anal Bioanal Chem 2004;378:1801-5.
17. Zhu YZ, Huang SH, Tan BK, Sun J, Whiteman M, Zhu YC. Antioxidants in Chinese herbal medicines: A biochemical perspective. Nat Prod Rep 2004;21:478-89.
18. Nakai K, Takenobu Y, Eguchi K, Takimizu H, Honjo K, Akimaru S, et al. The effects of OP-1206 alpha-CD on walking dysfunction in the rat neuropathic intermittent claudication model. Anesth Analg 2002;94:1537-41.
19. Suzuki Y, Goto K, Ishige A, Komatsu Y, Kamei J. Effect of Gosha-jinki-gan, a Kampo medicine, on enhanced platelet aggregation in streptozotocin-induced diabetic rats. Jpn J Pharmacol 1998;78:87-91.
20. Kanai S, Okano H, Abe H. Efficacy of toki-shigyakuka-gosyuyu-syokyo-to (danggui-sini-jia-wuzhuyu-shengjiang-tang) on peripheral circulation in autonomic disorders. Am J Chin Med 1997;25:69-78.
21. Zhang H, Sugiura Y, Goto Y. Aconiti tuber (Bushi) improves microcirculatory disturbances induced by endotoxin in rats. Phytother Res 2000;14:505-9.